Home > Healthcare IT > Global Statistics Representing Capecitabine Market Scenario by Application, Drug Formulati
Straits Research

Capecitabine Market

Capecitabine Market: Information by Application (Colon Cancer, Rectal Cancer, Breast Cancer, Others) Drug Formulation (Tablets, Capsules) and Regional Outlook-Forecast Till 2031

Table of Content Download Sample

Market Overview

Capecitabine is a chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Cancer is the second leading cause of death worldwide–around 9.6 million deaths every year are caused by cancer, WHO. In addition, more than 70% of deaths occur in low and middle-income countries. Thereon, with the increasing prevalence of cancer incidences worldwide, the overall demand for chemotherapeutic agents has increased significantly. Capecitabine has huge potential to meet the increasing need for new agents, which can more aggressively treat breast cancer in the earlier stages.

Global capecitabine market accounted for around USD 1,652 million in 2017 and is expected to grow at a healthy CAGR during the forecast period, 2023–2031.

Market Snapshot

market snapshot
Base Year
: 2022
Study Period
: 2021-2031
: %
Fastest Growing Market
: Europe
Largest Market
: America
Market Size
: USD 1,652 million in 2017
Get more information on this report Download Sample Report

Market Dynamics

  • Capecitabine Manufacturers
  • Raw Material Suppliers
  • Capecitabine Reselling Companies
  • Potential Investors
  • Research and Development Institutes
  • Traders, Distributors, and Suppliers of Capecitabine

Segmental Analysis

Global capecitabine market is segmented

By application and drug formulation.

By application, the market is segmented into colon cancer, rectal cancer, breast cancer, gastric cancer, and others.

By drug formulation, capecitabine market is segmented into tablets and capsules. Tablets segment is expected to dominate due to high production by manufacturers.

Regional Analysis

Geographically, the global capecitabine market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA).

The Americas is projected to dominate the global capecitabine market due to increasing prevalence of cancer in the region. Around 1,735,350 new cases of cancer were reported in 2018, National Cancer Institute. In line with this, many players are engaged in developing better treatment options. For instance, Puma Biotechnology has received positive results from the company’s lead drug Neratinib used in breast cancer. The treatment involves combination therapy with capecitabine.

Europe is the second largest market globally. This can be attributed to rising incidences of cancers, which is the second leading cause of death and morbidity in Europe. Around 3.7 million new cases occur each year in Europe, WHO. Novel therapies are the need of the hour in the region. Around USD 1.5 billion has been invested by the European government on cancer research, European Commission.

Asia Pacific is expected to witness significant growth. The region houses huge tobacco consuming population, killing more than 2.3 million every year. However, lack of awareness in the region is leading to delay in the detection of cancer. In 2018, most of the new cancer cases were diagnosed from Eastern Asia around 5.6 million, according to Cancer Organization. To educate people about symptoms and diagnosis of cancer, governments are conducting many programs and screening drives.

MEA is expected to witness steady growth as a result of growing burden of cancer on the Middle East & Africa region due to poor healthcare facilities.

Capecitabine Market Regional Analysis
Regional Growth Insights Download Free Sample

Top Key Players of Capecitabine Market

  1. Fresenius SE & Co. KGaA (Germany)
  2. Genentech, Inc. (U.S.)
  3. Dr Reddy Laboratories Ltd. (India)
  4. Cipla Inc. (India)
  5. Accord Healthcare Ltd. (U.K.)
  6. F. Hoffmann-La Roche Ltd. (Switzerland)
  7. Teva Pharma B.V., Sandoz Inc. (U.S.)
  8. Zentiva N.V. (Netherlands)
  9. Ranbaxy Laboratories Ltd. (India)

Report Scope

Report Metric Details
Forecast Period 2023-2031
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered
  1. By Application
    1. Colon Cancer
    2. Rectal Cancer
    3. Breast Cancer
    4. Gastric Cancer
    5. Others
  2. By Drug Formulation
    1. Tablets
    2. Capsules
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa

Capecitabine Market Segmentation

By Application

  • Colon Cancer
  • Rectal Cancer
  • Breast Cancer
  • Gastric Cancer
  • Others
  • By Drug Formulation

  • Tablets
  • Capsules
  • Regions Covered

    • America
      • North America
        • U.S.
        • Canada
        • Mexico
      • South America
    • Europe
      • Western Europe
        • Germany
        • France
        • UK
        • Italy
        • Spain
        • Rest of Western Europe
      • Eastern Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Rest of Asia Pacific
    • The Middle East & Africa
      • The Middle East
        • Saudi Arabia
        • UAE
        • Qatar
        • Rest of the Middle East
      • Africa

Frequently Asked Questions (FAQs)

What is the estimated growth rate (CAGR) of the Capecitabine Market?
Capecitabine Market size will growing at higher CAGR during the forecast period.
Some of the top prominent players in Capecitabine Market are, Fresenius SE & Co. KGaA (Germany), Genentech, Inc. (U.S.), Dr Reddy Laboratories Ltd. (India), Cipla Inc. (India), Accord Healthcare Ltd. (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharma B.V., Sandoz Inc. (U.S.), Zentiva N.V. (Netherlands), Ranbaxy Laboratories Ltd. (India), etc.
In the Capecitabine Market, America has established itself as the market leader with a significant market share.
The Europe region is projected to exhibit the highest rate of growth in the Capecitabine Market.
The global Capecitabine Market report is segmented as follows: By Application, By Drug Formulation
Price Starts From
USD 995

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Nippon Becton Dickinson
Argon Medical Devices
Johnson & Johnson
Need Assistance?
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Report Snapshot
Looking For Custom Report ?
Check Our License Options :

As featured on :

Trusted by Fortune 500
Over 30000+ subscribers